Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity
Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity
NCT ID: NCT02683317 Phase: NA Status: COMPLETED Enrollment: 110 Completion: 2017-10-31
Conditions
Retinopathy of Prematurity
Interventions
docosahexaenoic acid, sunflower oil
Summary
The purpose of this study is to evaluate whether docosahexaenoic acid given by enteral feeding prevent retinopathy of prematurity and/or diminish its severity in preterm infants.
Primary Outcome
Presence of retinopathy of prematurity (ROP)